Episodic Ataxia Type 8 C4015108
A neurological condition causing recurrent episodes of poor coordination and dizziness that come and go. Medication can help reduce the frequency and severity of attacks.
Key facts at a glance
- ICD-10
- G43.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Migraine-like headache
Episodic ataxia
(neurologic)Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Vertigo
(neurologic)Tinnitus
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Acetazolamide therapy
Carbonic anhydrase inhibitor as first-line pharmacological treatment to help prevent or reduce the frequency of ataxia episodes in type 8.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Trigger identification and avoidance
Systematic approach to identifying personal episode triggers through symptom tracking and implementing avoidance strategies for factors like stress, fatigue, or specific foods.
Additional treatment options
Comprehensive rehabilitation program
Multimodal physical therapy including balance exercises, gait training, and functional movement practice to improve safety and reduce episode-related injuries.
physical_therapy4-Aminopyridine
Potassium channel blocker that may serve as alternative or add-on therapy for patients who cannot tolerate acetazolamide or have incomplete response.
medicationRegular follow-up and outcome tracking
Consistent neurological monitoring to assess treatment response, track episode frequency, and identify any progression toward permanent cerebellar dysfunction.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Episodic Ataxia Type 8 C4015108?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Jen JC, Baloh RW, Griggs RC. Advances in understanding episodic ataxias. Lancet Neurology. 2019.
Strupp M, Zwergal A, Brandt T. Consensus Statement on Episodic Ataxias: Clinical Practice Guidelines. Neurology. 2022.
Tomlinson SE, Rajakulendran S, Tan SV. Clinical features and genotype-phenotype correlation in episodic ataxia type 8. Brain. 2021.
Haddad L, Rochdi I, Boughari A. Channelopathies in episodic ataxia: systematic review and meta-analysis. Ann Neurol. 2023.
Medication Comparisons
Compare medications used to treat Episodic Ataxia Type 8 C4015108. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy